A Smart + Strong Site
Subscribe to:
Newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

August 16, 2013

Strong Support for Vaccinating Young Gay Men for HPV

Numerous studies have suggested that the vaccine for human papillomavirus (HPV) strongly benefits young gay men, aidsmap reports. A syndicate of sexual health physicians have published an editorial in the journal Sexually Transmitted Infections in which they spotlight high rates of HPV-related anal disease in gay men and show how the vaccine is both cost-effective and beneficial to health when given to gay men younger than 26.

The vaccine Gardasil covers four strains of the virus. HPV 16 and 18 are the most high risk in terms of prompting the development of precancerous and cancerous cell changes in the anus. Compared with other risk groups, gay men have the highest incidence of HPV-related anal disease.

The Centers for Disease Control and Prevention (CDC) recommends all 11- and 12-year-old boys receive the vaccination, as well as males up to age 26.

The editorial notes that Gardasil was effective in a study of HIV-positive gay men. In those who began the study either infected or uninfected with HPV 16 or 18, the vaccine led 98 percent of the men to produce antibodies against the four high-risk strains of HPV.

To read the aidsmap story, click here.

To read the journal article, click here.

Search: HPV, human papillomavirus, vaccination, Gardasil, aidsmap, anal disease, Centers for Disease Control and Prevention, CDC, Sexually Transmitted Infections.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)


[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    Hillcrester
    Ramona
    California


    Sin_Grinder
    Reno
    Nevada


    jimmy807
    San Antonio
    Texas


    clintonjrsyr
    syracuse
    New York
Click here to join POZ Personals!
Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.